HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jason Gotlib Selected Research

von Willebrand Diseases (von Willebrand's Disease)

1/2022Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jason Gotlib Research Topics

Disease

52Neoplasms (Cancer)
04/2024 - 02/2004
32Systemic Mastocytosis
04/2024 - 10/2005
24Eosinophilia
03/2024 - 01/2005
21Primary Myelofibrosis (Myelosclerosis)
10/2023 - 03/2012
14Pdgfra-Associated Chronic Eosinophilic Leukemia
03/2024 - 04/2004
14Mastocytosis
03/2024 - 08/2006
13Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 01/2005
12Hypereosinophilic Syndrome (Loeffler Endocarditis)
12/2015 - 03/2003
10Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2020 - 10/2003
7Leukemia
01/2022 - 03/2004
7Anemia
11/2019 - 11/2006
7Splenomegaly
01/2018 - 10/2013
6Mast Cell Activation Disorders (Mast-Cell Disease)
03/2024 - 08/2006
6Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2008
5Polycythemia Vera
02/2024 - 04/2006
5Hypersensitivity (Allergy)
01/2022 - 01/2021
5Blast Crisis (Blast Phase)
12/2020 - 08/2004
5Thrombocytopenia (Thrombopenia)
11/2019 - 03/2012
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2014 - 04/2004
4Thrombosis (Thrombus)
12/2022 - 03/2014
4Thrombocytosis (Thrombocythemia)
01/2022 - 12/2011
4Myeloproliferative Disorders (Myeloproliferative Disorder)
07/2006 - 01/2005
3Mast-Cell Leukemia (Leukemia, Mast Cell)
04/2024 - 10/2005
3Hereditary alpha-tryptasemia syndrome
10/2023 - 11/2021
3Essential Thrombocythemia
01/2022 - 03/2014
3BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative)
01/2020 - 09/2013
3Chronic Neutrophilic Leukemia
01/2020 - 09/2013
2Philadelphia Chromosome
01/2021 - 01/2018
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 12/2014
2Chromosome Aberrations (Chromosome Abnormalities)
01/2021 - 03/2003
2Multiple Myeloma
09/2018 - 04/2016
2Lymphoma (Lymphomas)
10/2017 - 01/2017
2Fever (Fevers)
03/2017 - 04/2014
2Fatigue
01/2017 - 04/2013
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2010 - 01/2005
1Cutaneous Mastocytosis
04/2024
1Leukocytosis (Pleocytosis)
04/2024
1Polycythemia (Erythrocytosis)
02/2024
1Fibrosis (Cirrhosis)
10/2023
1Abnormal Karyotype
01/2023

Drug/Important Bio-Agent (IBA)

21ruxolitinibIBA
10/2023 - 03/2012
17Imatinib Mesylate (Gleevec)FDA Link
12/2022 - 03/2003
15Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
12/2022 - 01/2006
12Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2024 - 03/2003
12Phosphotransferases (Kinase)IBA
01/2017 - 02/2004
11Tryptases (Tryptase)IBA
04/2024 - 10/2014
10midostaurinIBA
01/2023 - 10/2005
9Janus Kinase InhibitorsIBA
10/2022 - 01/2013
8Tyrosine Kinase InhibitorsIBA
01/2018 - 05/2003
8Tyrosine (L-Tyrosine)FDA Link
01/2017 - 02/2004
7avapritinibIBA
06/2023 - 12/2021
6Janus KinasesIBA
01/2023 - 08/2010
6Adrenal Cortex Hormones (Corticosteroids)IBA
10/2019 - 08/2006
5Proteins (Proteins, Gene)FDA Link
11/2020 - 03/2004
5Janus Kinase 1IBA
01/2018 - 12/2013
4Hydroxyurea (Hydrea)FDA LinkGeneric
10/2022 - 10/2020
4CalreticulinIBA
01/2022 - 03/2014
4Biomarkers (Surrogate Marker)IBA
10/2021 - 04/2014
4CytokinesIBA
01/2021 - 01/2006
4Janus Kinase 2IBA
01/2021 - 12/2013
3Syntex adjuvant formulationIBA
02/2024 - 01/2021
3CladribineFDA LinkGeneric
01/2022 - 08/2006
3Core Binding Factors (Core-Binding Factor)IBA
01/2021 - 01/2018
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021 - 10/2005
3Thrombopoietin (c-mpl Ligand)IBA
06/2014 - 12/2011
3Farnesyltranstransferase (Farnesyltransferase)IBA
03/2008 - 01/2005
2Arthropod VenomsIBA
04/2024 - 01/2022
2Immunoglobulin E (IgE)IBA
01/2022 - 01/2022
2Alkaline PhosphataseIBA
01/2021 - 12/2019
2Azacitidine (5 Azacytidine)FDA Link
11/2020 - 01/2016
2Hemoglobins (Hemoglobin)IBA
11/2019 - 03/2014
2Lenalidomide (CC 5013)FDA Link
09/2018 - 01/2016
2AntibodiesIBA
01/2018 - 12/2015
2Interferon-alpha (Interferon Alfa)IBA
10/2016 - 08/2006
2Cytarabine (Cytosar-U)FDA LinkGeneric
12/2014 - 11/2010
2Etoposide (VP 16)FDA LinkGeneric
12/2014 - 11/2010
2Mitoxantrone (Novantrone)FDA LinkGeneric
12/2014 - 11/2010
2ErythropoietinFDA Link
06/2014 - 01/2013
2DNA (Deoxyribonucleic Acid)IBA
11/2013 - 12/2012
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2013 - 01/2009
2Interleukin-5 (Interleukin 5)IBA
04/2012 - 01/2006
2Dasatinib (BMS 354825)FDA Link
08/2011 - 08/2006
2mepolizumabIBA
03/2010 - 02/2010
2Alemtuzumab (Campath)FDA Link
03/2010 - 02/2010
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2010 - 01/2005
2Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
02/2010 - 01/2006
2beta CateninIBA
03/2009 - 08/2004
2tipifarnib (R115777)IBA
03/2008 - 02/2007
2Platelet-Derived Growth Factor alpha ReceptorIBA
01/2005 - 03/2003
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2024
1Penicillins (Penicillin)FDA Link
04/2024
1pemigatinibIBA
03/2024
1HepcidinsIBA
02/2024
1Serum Amyloid P-ComponentIBA
10/2023
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2022

Therapy/Procedure

45Therapeutics
12/2022 - 10/2003
5Drug Therapy (Chemotherapy)
01/2020 - 11/2010
3Cell Transplantation
03/2024 - 01/2016
2Transplantation
03/2024 - 01/2015
2Hematopoietic Stem Cell Transplantation
01/2017 - 10/2016